Simultaneous application of two neurotrophic factors after spinal cord injury

Debra M. Bohnert, Scott Purvines, Scott Shapiro, Richard B. Borgens

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We have studied the application of voltage gradients to injured spinal cord which enhanced regeneration of axons and reduced their retrograde degeneration after injury. This led to an implanted electronic device producing electrical fields sufficient to induce regeneration in both ascending and descending tracts of white matter (called oscillating field stimulation [OFS]), which has been associated with behavioral recovery in animal models of spinal cord injury (SCI). OFS has also proven to benefit neurologically complete spinal cord injured dogs and humans in clinical trials. These studies, however, have failed to confirm benefit if applied after the sub-acute period of SCI. Here we report on combining OFS with the application of a non-toxic neurotrophic factor, inosine, using a behavioral model for "chronic" SCI, the cutaneous trunci muscle (CTM) reflex in adult guinea pigs. Inosine was delivered subcutaneously in guinea pigs for 28 days using implantable "osmotic pumps" - alone or in combination with OFS. In all animals, experimental and control treatments were withheld for three months after a right lateral hemisection of the thoracic spinal cord. Both inosine and the combination therapy produced a statistically significant recovery of CTM receptive fields silenced permanently by spinal cord hemisection in controls - though the combination therapy enhanced the time of the appearance of recovered regions of skin. Retransection of the cord in three recovered animals eliminated the CTM recovery confirming changes in neural connections were restricted to the cord and not due to changes in cutaneous peripheral innervation. Morphometry of anterogradely labeled white matter revealed a statistically enhanced regeneration of ascending and descending projections in animals treated with the combination "therapy" compared to inosine alone. These data suggest that combining neurotrophic factors of differing modes of action likely enhance the outcome from "chronic" SCI.

Original languageEnglish
Pages (from-to)846-863
Number of pages18
JournalJournal of Neurotrauma
Volume24
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Nerve Growth Factors
Inosine
Spinal Cord Injuries
Spinal Cord
Skin
Regeneration
Muscles
Guinea Pigs
Retrograde Degeneration
Therapeutics
Axons
Reflex
Thorax
Animal Models
Clinical Trials
Dogs
Equipment and Supplies
Wounds and Injuries
White Matter

Keywords

  • Inosine
  • Nerve regeneration
  • Oscillating field stimulation (OFS)
  • Osmotic pumps
  • Spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Simultaneous application of two neurotrophic factors after spinal cord injury. / Bohnert, Debra M.; Purvines, Scott; Shapiro, Scott; Borgens, Richard B.

In: Journal of Neurotrauma, Vol. 24, No. 5, 05.2007, p. 846-863.

Research output: Contribution to journalArticle

Bohnert, Debra M. ; Purvines, Scott ; Shapiro, Scott ; Borgens, Richard B. / Simultaneous application of two neurotrophic factors after spinal cord injury. In: Journal of Neurotrauma. 2007 ; Vol. 24, No. 5. pp. 846-863.
@article{4edb554559c24dd6b32ebcb62621e394,
title = "Simultaneous application of two neurotrophic factors after spinal cord injury",
abstract = "We have studied the application of voltage gradients to injured spinal cord which enhanced regeneration of axons and reduced their retrograde degeneration after injury. This led to an implanted electronic device producing electrical fields sufficient to induce regeneration in both ascending and descending tracts of white matter (called oscillating field stimulation [OFS]), which has been associated with behavioral recovery in animal models of spinal cord injury (SCI). OFS has also proven to benefit neurologically complete spinal cord injured dogs and humans in clinical trials. These studies, however, have failed to confirm benefit if applied after the sub-acute period of SCI. Here we report on combining OFS with the application of a non-toxic neurotrophic factor, inosine, using a behavioral model for {"}chronic{"} SCI, the cutaneous trunci muscle (CTM) reflex in adult guinea pigs. Inosine was delivered subcutaneously in guinea pigs for 28 days using implantable {"}osmotic pumps{"} - alone or in combination with OFS. In all animals, experimental and control treatments were withheld for three months after a right lateral hemisection of the thoracic spinal cord. Both inosine and the combination therapy produced a statistically significant recovery of CTM receptive fields silenced permanently by spinal cord hemisection in controls - though the combination therapy enhanced the time of the appearance of recovered regions of skin. Retransection of the cord in three recovered animals eliminated the CTM recovery confirming changes in neural connections were restricted to the cord and not due to changes in cutaneous peripheral innervation. Morphometry of anterogradely labeled white matter revealed a statistically enhanced regeneration of ascending and descending projections in animals treated with the combination {"}therapy{"} compared to inosine alone. These data suggest that combining neurotrophic factors of differing modes of action likely enhance the outcome from {"}chronic{"} SCI.",
keywords = "Inosine, Nerve regeneration, Oscillating field stimulation (OFS), Osmotic pumps, Spinal cord injury",
author = "Bohnert, {Debra M.} and Scott Purvines and Scott Shapiro and Borgens, {Richard B.}",
year = "2007",
month = "5",
doi = "10.1089/neu.2006.0101",
language = "English",
volume = "24",
pages = "846--863",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Simultaneous application of two neurotrophic factors after spinal cord injury

AU - Bohnert, Debra M.

AU - Purvines, Scott

AU - Shapiro, Scott

AU - Borgens, Richard B.

PY - 2007/5

Y1 - 2007/5

N2 - We have studied the application of voltage gradients to injured spinal cord which enhanced regeneration of axons and reduced their retrograde degeneration after injury. This led to an implanted electronic device producing electrical fields sufficient to induce regeneration in both ascending and descending tracts of white matter (called oscillating field stimulation [OFS]), which has been associated with behavioral recovery in animal models of spinal cord injury (SCI). OFS has also proven to benefit neurologically complete spinal cord injured dogs and humans in clinical trials. These studies, however, have failed to confirm benefit if applied after the sub-acute period of SCI. Here we report on combining OFS with the application of a non-toxic neurotrophic factor, inosine, using a behavioral model for "chronic" SCI, the cutaneous trunci muscle (CTM) reflex in adult guinea pigs. Inosine was delivered subcutaneously in guinea pigs for 28 days using implantable "osmotic pumps" - alone or in combination with OFS. In all animals, experimental and control treatments were withheld for three months after a right lateral hemisection of the thoracic spinal cord. Both inosine and the combination therapy produced a statistically significant recovery of CTM receptive fields silenced permanently by spinal cord hemisection in controls - though the combination therapy enhanced the time of the appearance of recovered regions of skin. Retransection of the cord in three recovered animals eliminated the CTM recovery confirming changes in neural connections were restricted to the cord and not due to changes in cutaneous peripheral innervation. Morphometry of anterogradely labeled white matter revealed a statistically enhanced regeneration of ascending and descending projections in animals treated with the combination "therapy" compared to inosine alone. These data suggest that combining neurotrophic factors of differing modes of action likely enhance the outcome from "chronic" SCI.

AB - We have studied the application of voltage gradients to injured spinal cord which enhanced regeneration of axons and reduced their retrograde degeneration after injury. This led to an implanted electronic device producing electrical fields sufficient to induce regeneration in both ascending and descending tracts of white matter (called oscillating field stimulation [OFS]), which has been associated with behavioral recovery in animal models of spinal cord injury (SCI). OFS has also proven to benefit neurologically complete spinal cord injured dogs and humans in clinical trials. These studies, however, have failed to confirm benefit if applied after the sub-acute period of SCI. Here we report on combining OFS with the application of a non-toxic neurotrophic factor, inosine, using a behavioral model for "chronic" SCI, the cutaneous trunci muscle (CTM) reflex in adult guinea pigs. Inosine was delivered subcutaneously in guinea pigs for 28 days using implantable "osmotic pumps" - alone or in combination with OFS. In all animals, experimental and control treatments were withheld for three months after a right lateral hemisection of the thoracic spinal cord. Both inosine and the combination therapy produced a statistically significant recovery of CTM receptive fields silenced permanently by spinal cord hemisection in controls - though the combination therapy enhanced the time of the appearance of recovered regions of skin. Retransection of the cord in three recovered animals eliminated the CTM recovery confirming changes in neural connections were restricted to the cord and not due to changes in cutaneous peripheral innervation. Morphometry of anterogradely labeled white matter revealed a statistically enhanced regeneration of ascending and descending projections in animals treated with the combination "therapy" compared to inosine alone. These data suggest that combining neurotrophic factors of differing modes of action likely enhance the outcome from "chronic" SCI.

KW - Inosine

KW - Nerve regeneration

KW - Oscillating field stimulation (OFS)

KW - Osmotic pumps

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=34249095409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249095409&partnerID=8YFLogxK

U2 - 10.1089/neu.2006.0101

DO - 10.1089/neu.2006.0101

M3 - Article

C2 - 17518539

AN - SCOPUS:34249095409

VL - 24

SP - 846

EP - 863

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 5

ER -